ProQR (PRQR) - Utang jangka cendhak perusahaan

ProQR Therapeutics NV - logo grafis emiten PRQR

The price trend for ProQR Therapeutics N.V. (PRQR) allows for an assessment of its RNA-based drug development strategy. The current indicator stands at 0.01. The business relies on partnerships with industry behemoths, confirming confidence in the team's competencies. Meanwhile, a steady cash flow is absent, as the company allocates resources to research and does not yet have regular sales.

PRQR Utang jangka cendhak ProQR Therapeutics N.V. (04.07.2022 - 30.10.2026)
Produk seri ProQR Therapeutics N.V.

Long-term investing requires strict liquidity control to minimize credit risks. The specificity of ProQR Therapeutics N.V. (PRQR) lies in the monetization of the Axiomer platform through strategic partnerships. This current liability metric accumulates all obligations with a maturity of up to one year, measuring the short-term financial burden. Stable advances from pharma behemoths allow the company to effectively service these loans. Such a capital structure guarantees high business resilience.

Karo sapa ProQR Therapeutics N.V. saingan

TEM - Utang jangka cendhak perusahaan|Kewajiban jangka cendhak QGEN|Ionis Pharma (IONS) - Utang jangka cendhak perusahaan|Repligen Inc. - Silihan lan utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan Avidity Biosciences|Utang jangka cendhak crisprtx.com CRSP|Utang jangka cendhak perusahaan GeneDx (WGS)|Ultragenyx Pharmaceutical Inc. (RARE) - Tanggungan jangka cendhak|Utang jangka cendhak perusahaan Beam Therapeutics Corp BEAM|Silihan lan utang jangka cendhak perusahaan SRPT|TWST: Kewajiban jangka cendhak perusahaan|Silihan lan utang jangka cendhak perusahaan TXG (10xgenomics.com)|NTLA (Intellia Therapeutics, Inc.) - Kewajiban jangka cendhak perusahaan|STOK: Gedhene kewajiban jangka cendhak|BLFS (BioLife Corp) - Utang jangka cendhak perusahaan|WVE: Silihan lan utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan MAZE|SION - Utang jangka cendhak|Utang jangka cendhak perusahaan Prime Medicine PRME|Silihan lan utang jangka cendhak perusahaan TSHA|uniQure Corp - Utang jangka cendhak perusahaan|MGTX - Utang jangka cendhak perusahaan|REGENXBIO Inc. (RGNX) - Utang jangka cendhak perusahaan|Kewajiban jangka cendhak SLDB (solidbio.com)|OCGN (Ocugen) - Utang jangka cendhak perusahaan|Utang jangka cendhak Pacific Biosciences of California, Inc. PACB|Kewajiban jangka cendhak perusahaan BNTC (Benitec)|Utang jangka cendhak perusahaan Design Corp (DSGN)|Rocket Pharmaceuticals - Kewajiban jangka cendhak perusahaan|Gedhene kewajiban jangka cendhak FDMT (4dmoleculartherapeutics.com)|Lexeo - Utang jangka cendhak perusahaan|Gunggunge utang jangka cendhak Korro Bio, Inc. KRRO|EDIT: Utang jangka cendhak perusahaan|Kewajiban jangka cendhak perusahaan Silence Therapeutics Corp|Utang jangka cendhak perusahaan Codexis Inc|sangamo.com (SGMO) - Gunggunge utang jangka cendhak|Kewajiban jangka cendhak perusahaan NAUT (Nautilus Biotechnology)|MGX (Metagenomi Inc.) - Silihan lan utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan Precision BioSciences DTIL|GBIO: Tanggungan utang jangka cendhak perusahaan|BOLD: Kewajiban jangka cendhak perusahaan|Gunggunge utang jangka cendhak Exicure, Inc. XCUR|IMNN (imunon.com) - Kewajiban jangka cendhak perusahaan|PHIO (Phio Pharmaceuticals Corp.) - Utang jangka cendhak perusahaan|Kewajiban jangka cendhak perusahaan MBIO|TransCode (RNAZ) - Gunggunge utang jangka cendhak|Utang jangka cendhak perusahaan Bionano Genomics, Inc. (BNGO)|APDN: Kewajiban jangka cendhak|Utang jangka cendhak perusahaan bluebird bio BLUE|Silihan lan utang jangka cendhak perusahaan IPA|OMGA - Utang jangka cendhak perusahaan|Tanggungan jangka cendhak Singular Genomics Corp (OMIC)|Regulus Therapeutics (RGLS) - Utang jangka cendhak perusahaan|syros.com - Silihan lan utang jangka cendhak perusahaan|TBIO (Telesis Bio) - Utang jangka cendhak perusahaan|Tanggungan utang jangka cendhak perusahaan TCON (TRACON Pharmaceuticals Inc.)|Utang jangka cendhak perusahaan Unity Bio (UBX)